Surufatinib plus toripalimab for first-line treatment of advanced non-small cell lung cancer (NSCLC) with PD-L1 positive expression: A multicenter, single-arm phase 2 studyYing Cheng,Lin Shen,Zhendong Chen,Feng Ye,Xianjun Yu,Xing Zhang,Dongmei Ji,Baorui Liu,Lijie Song,Chunjiao Wu,Ming Lu,Wei Chen,Jingxun Wu,Heli Gao,Desheng Weng,Weina Shen,Rutian Li,Minjie Yang,Jinghong Zhou,Haiyan Shi, Panfeng Tan,Songhua Fan,Michael Shi,Weiguo SuCANCER RESEARCH（2023）引用 0|浏览9暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
